Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Once-weekly subcutaneous epoetin beta in hemodialysis patients
2004-000983-29Phase 4Completed
- Sponsor
- Roche
- Start
- Oct 2004
- Modality
- Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes, Colony Stimulating Factors → Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of epoetin beta in anemia of renal disease, sponsored by Roche. Primary endpoints: Main parameters of efficacy and Hemoglobin level variability. Started Oct 2004; status: completed.
02
Drugs
epoetin beta
03
Conditions
anemia of renal disease
Beyond the preview
Go deeper on 2004-000983-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000983-29.